Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Relationship between damage clustering and mortality in systemic lupus erythematosus in early and late stages of the disease: cluster analyses in a large cohort from the Spanish Society of Rheumatology Lupus Registry.
Pego-Reigosa JM, Lois-Iglesias A, Rúa-Figueroa Í, Galindo M, Calvo-Alén J, de Uña-Álvarez J, Balboa-Barreiro V, Ibáñez Ruan J, Olivé A, Rodríguez-Gómez M, Fernández Nebro A, Andrés M, Erausquin C, Tomero E, Horcada Rubio L, Uriarte Isacelaya E, Freire M, Montilla C, Sánchez-Atrio AI, Santos-Soler G, Zea A, Díez E, Narváez J, Blanco-Alonso R, Silva-Fernández L, Ruiz-Lucea ME, Fernández-Castro M, Hernández-Beriain JÁ, Gantes-Mora M, Hernández-Cruz B, Pérez-Venegas J, Pecondón-Español Á, Marras Fernández-Cid C, Ibáñez-Barcelo M, Bonilla G, Torrente-Segarra V, Castellví I, Alegre JJ, Calvet J, Marenco de la Fuente JL, Raya E, Vázquez-Rodríguez TR, Quevedo-Vila V, Muñoz-Fernández S, Otón T, Rahman A, López-Longo FJ. Pego-Reigosa JM, et al. Among authors: marenco de la fuente jl. Rheumatology (Oxford). 2016 Jul;55(7):1243-50. doi: 10.1093/rheumatology/kew049. Epub 2016 Mar 27. Rheumatology (Oxford). 2016. PMID: 27018057 Free article.
Characterization of Patients With Lupus Nephritis Included in a Large Cohort From the Spanish Society of Rheumatology Registry of Patients With Systemic Lupus Erythematosus (RELESSER).
Galindo-Izquierdo M, Rodriguez-Almaraz E, Pego-Reigosa JM, López-Longo FJ, Calvo-Alén J, Olivé A, Fernández-Nebro A, Martinez-Taboada V, Vela-Casasempere P, Freire M, Narváez FJ, Rosas J, Ibáñez-Barceló M, Uriarte E, Tomero E, Zea A, Horcada L, Torrente V, Castellvi I, Calvet J, Menor-Almagro R, Zamorano MAA, Raya E, Díez-Álvarez E, Vázquez-Rodríguez T, García de la Peña P, Movasat A, Andreu JL, Richi P, Marras C, Montilla-Morales C, Hernández-Cruz B, Marenco de la Fuente JL, Gantes M, Úcar E, Alegre-Sancho JJ, Manero J, Ibáñez-Ruán J, Rodríguez-Gómez M, Quevedo V, Hernández-Beriaín J, Silva-Fernández L, Alonso F, Pérez S, Rúa-Figueroa I; RELESSER Group, from the Spanish Society of Rheumatology Systemic Autoimmune Diseases Study Group (EASSER). Galindo-Izquierdo M, et al. Among authors: marenco de la fuente jl. Medicine (Baltimore). 2016 Mar;95(9):e2891. doi: 10.1097/MD.0000000000002891. Medicine (Baltimore). 2016. PMID: 26945378 Free PMC article.
Genome-wide pathway analysis identifies VEGF pathway association with oral ulceration in systemic lupus erythematosus.
Aterido A, Julià A, Carreira P, Blanco R, López-Longo JJ, Venegas JJP, Olivé À, Andreu JL, Aguirre-Zamorano MÁ, Vela P, Nolla JM, Marenco-de la Fuente JL, Zea A, Pego JM, Freire M, Díez E, López-Lasanta M, López-Corbeto M, Palau N, Tortosa R, Gelpí JL, Absher D, Myers RM, Fernández-Nebro A, Marsal S. Aterido A, et al. Among authors: marenco de la fuente jl. Arthritis Res Ther. 2017 Jun 15;19(1):138. doi: 10.1186/s13075-017-1345-6. Arthritis Res Ther. 2017. PMID: 28619073 Free PMC article.
[Update of the Consensus Statement of the Spanish Society of Rheumatology on the management of biologic therapies in rheumatoid arthritis].
Tornero Molina J, Sanmartí Sala R, Rodríguez Valverde V, Martín Mola E, Marenco de la Fuente JL, González Álvaro I, Muñoz Fernández S, Gómez-Reino Carnota J, Carreño Pérez L, Batlle Gualda E, Balsa Criado A, Andreu JL, Alvaro-Gracia JM, Martínez López JA, Loza Santamaría E. Tornero Molina J, et al. Among authors: marenco de la fuente jl. Reumatol Clin. 2010 Jan-Feb;6(1):23-36. doi: 10.1016/j.reuma.2009.10.006. Epub 2009 Dec 6. Reumatol Clin. 2010. PMID: 21794674 Free article. Spanish.
[Resistant orbital pseudotumor treated with rituximab in a patient with systemic lupus erythematosus. A case presentation].
Escudero González CM, Rodríguez Montero S, Martínez Pérez R, Pastor Mañosa C, Velloso Feijoo ML, Marenco de la Fuente JL. Escudero González CM, et al. Among authors: marenco de la fuente jl. Reumatol Clin. 2010 Jul-Aug;6(4):214-6. doi: 10.1016/j.reuma.2009.07.011. Epub 2010 Apr 10. Reumatol Clin. 2010. PMID: 21794716 Free article. Spanish.
Anakinra versus Baricitinib: Different Strategies for Patients Hospitalized with COVID-19.
García-García JA, Pérez-Quintana M, Ramos-Giráldez C, Cebrián-González I, Martín-Ponce ML, Del Valle-Villagrán J, Navarro-Puerto MA, Sánchez-Villegas J, Gómez-Herreros R, Manoja-Bustos I, León-Martí D, Serrano-Rodríguez L, de Miguel-Albarreal A, Velasco-Romero MJ, Mula-Falcón F, Fernández-Pérez P, Melguizo-Moya I, Pérez-Quintana MJ, Romero-Molina G, Vergara-López S, Marenco-de la Fuente JL, Marín-Martín J, Mira-Escarti JA. García-García JA, et al. Among authors: marenco de la fuente jl. J Clin Med. 2021 Sep 6;10(17):4019. doi: 10.3390/jcm10174019. J Clin Med. 2021. PMID: 34501467 Free PMC article.
[Consensus on the Use of Rituximab in Rheumatoid Arthritis. A document with evidence-based recommendations. Grupo de Expertos en Rituximab. ].
Martín Mola E, Hernández B, García-Arias M, Alvaro-Gracia JM, Balsa A, Reino JG, Marenco de la Fuente JL, Martínez-Taboada V, Ivorra JA, Sanmartí R; el grupo de Expertos en Rituximab. Martín Mola E, et al. Among authors: marenco de la fuente jl. Reumatol Clin. 2011 Jan-Feb;7(1):30-44. doi: 10.1016/j.reuma.2010.11.002. Epub 2010 Dec 17. Reumatol Clin. 2011. PMID: 21794777 Free article. Spanish.
III Actualización del Consenso de la Sociedad Española de Reumatología sobre terapia biológica en la artritis reumatoide.
Rodríguez-Valverde V, Cáliz Cáliz R, Alvaro-Gracia Álvaro JM, Marenco de la Fuente JL, Mulero Mendoza J, Tornero Molina J, Andréu Sánchez JL, Ballina García FJ, Batlle Gualda E, Cañete Crespillo JD, Carbonell Abelló J, Carreño Pérez L, Figueroa Pedrosa M, Gómez-Reino Carnota J, González García T, Laffon Roca A, Martín Mola E, Pascual Gómez E, Sanmartí Sala R, Salazar Vallinas JM, Valverde García J. Rodríguez-Valverde V, et al. Among authors: marenco de la fuente jl. Reumatol Clin. 2006 Mar;2 Suppl 2:S52-9. doi: 10.1016/S1699-258X(06)73097-2. Epub 2008 Dec 10. Reumatol Clin. 2006. PMID: 21794377 Free article. Spanish. No abstract available.
Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis.
Buch MH, Smolen JS, Betteridge N, Breedveld FC, Burmester G, Dörner T, Ferraccioli G, Gottenberg JE, Isaacs J, Kvien TK, Mariette X, Martin-Mola E, Pavelka K, Tak PP, van der Heijde D, van Vollenhoven RF, Emery P; Rituximab Consensus Expert Committee. Buch MH, et al. Ann Rheum Dis. 2011 Jun;70(6):909-20. doi: 10.1136/ard.2010.144998. Epub 2011 Mar 6. Ann Rheum Dis. 2011. PMID: 21378402 Free PMC article.
21 results